These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7932753)

  • 1. Domains of interaction between alpha interferon and its receptor components.
    Uzé G; Di Marco S; Mouchel-Vielh E; Monneron D; Bandu MT; Horisberger MA; Dorques A; Lutfalla G; Mogensen KE
    J Mol Biol; 1994 Oct; 243(2):245-57. PubMed ID: 7932753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists.
    Pan M; Kalie E; Scaglione BJ; Raveche ES; Schreiber G; Langer JA
    Biochemistry; 2008 Nov; 47(46):12018-27. PubMed ID: 18937499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2.
    Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K
    J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR-1 chimeras.
    Goldman LA; Cutrone EC; Dang A; Hao X; Lim JK; Langer JA
    Biochemistry; 1998 Sep; 37(37):13003-10. PubMed ID: 9737881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology model of human interferon-alpha 8 and its receptor complex.
    Seto MH; Harkins RN; Adler M; Whitlow M; Church WB; Croze E
    Protein Sci; 1995 Apr; 4(4):655-70. PubMed ID: 7613464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for glycosphingolipid modification of the type 1 IFN receptor.
    Ghislain J; Lingwood CA; Fish EN
    J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
    Platis D; Foster GR
    J Interferon Cytokine Res; 2003 Nov; 23(11):655-66. PubMed ID: 14651780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
    Cutrone EC; Langer JA
    J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
    Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
    Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
    Piehler J; Schreiber G
    J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic activities of natural and synthetic type I interferons.
    Pfeffer LM
    Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-63-S9-69. PubMed ID: 9208874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2.
    Lu J; Chuntharapai A; Beck J; Bass S; Ow A; De Vos AM; Gibbs V; Kim KJ
    J Immunol; 1998 Feb; 160(4):1782-8. PubMed ID: 9469437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of IFN-alpha2 and IFN-alpha8 exhibits synergistic antiproliferative activity on renal cell carcinoma (RCC) cell lines through increased binding affinity for IFNAR-2.
    Tanimoto T; Yamamoto S; Taniai M; Taniguchi M; Ariyasu H; Ushio C; Aga M; Mukai Y; Tsutsumi Y; Ariyasu T; Ohta T; Fukuda S
    J Interferon Cytokine Res; 2007 Jun; 27(6):517-23. PubMed ID: 17572016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of cloned type I interferon receptor subunits to differential ligand binding.
    Cutrone EC; Langer JA
    FEBS Lett; 1997 Mar; 404(2-3):197-202. PubMed ID: 9119063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
    Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
    J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha.
    Hamilton JA; Whitty GA; Kola I; Hertzog PJ
    J Immunol; 1996 Apr; 156(7):2553-7. PubMed ID: 8786318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of human type I interferon receptors in the mouse liver.
    Tochizawa S; Muraguchi M; Ohmoto Y; Oga K; Mori T
    Biochem Biophys Res Commun; 2006 Jul; 346(1):61-6. PubMed ID: 16750512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structural basis for interferon-alpha-receptor interactions.
    Kumaran J; Wei L; Kotra LP; Fish EN
    FASEB J; 2007 Oct; 21(12):3288-96. PubMed ID: 17517919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human interferons alpha, beta and omega.
    Bekisz J; Schmeisser H; Hernandez J; Goldman ND; Zoon KC
    Growth Factors; 2004 Dec; 22(4):243-51. PubMed ID: 15621727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
    Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
    J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.